<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00719511</url>
  </required_header>
  <id_info>
    <org_study_id>ZU-SkinSIT-002</org_study_id>
    <nct_id>NCT00719511</nct_id>
  </id_info>
  <brief_title>Study of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects by Epicutaneous Allergen Administration</brief_title>
  <official_title>Single Center Phase I/IIa, Placebo Controlled, Randomized, Double-blind, Dose-response Study to Assess the Optimal Dose as Well as Clinical Efficacy and Safety of a Novel Method of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects by Epicutaneous Allergen Administration</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of patch as specific immunotherapy in allergic patients
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2008</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">November 2009</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of the efficacy of the placebo with that of three different test doses of the epicutaneous pollen allergen administration evaluated by visual analog scales after the treatment</measure>
    <time_frame>2010</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">132</enrollment>
  <condition>Allergies</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patch allergen dose 1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patch allergen dose 2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patch allergen dose 3</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Purified allergen dose 1 integrated in a Patch system</intervention_name>
    <description>Epicutaneous application of a patch</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Purified allergen dose 2 integrated in a Patch system</intervention_name>
    <description>Epicutaneous application of a patch</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Purified allergen dose 3 integrated in a Patch system</intervention_name>
    <description>Epicutaneous application of a patch</description>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Purified allergen integrated in a Patch system</intervention_name>
    <description>Epicutaneous application of a patch</description>
    <arm_group_label>4</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Written informed consent

          -  History of grass pollen allergic rhinitis

          -  Male and female between 18 years to 65 years

          -  Positive skin-prick test to grass pollen

          -  Positive conjunctival provocation test

        Exclusion criteria:

          -  Eczematous skin lesions on the upper arms

          -  Perennial allergic rhinitis

          -  Symptoms of infectious disease with rhinitis in between the last 2 weeks

          -  Surgical intervention in between the last 30 days

          -  Pregnancy or nursing

          -  History of HIV or AIDS

          -  History of mastocytosis (cutaneous or systemic)

          -  History of significant cardiovascular disease

          -  Hypertension (blood pressure &gt; 160 / 95)

          -  History of significant pulmonary, renal and/or hepatic disease

          -  History of significant hematological disorder

          -  Moderate or severe asthma

          -  History of malignancy

          -  History of neurological or psychiatric disease

          -  History of autoimmune disease

          -  Antihistamines with longed half-lives in the last week

          -  Systemic or topical steroids for 5 days

          -  Active infectious disease

          -  Contraindicated medications:

               -  immunosuppressive agents

               -  Betablockers

               -  ACE-inhibitors, AT 2 Antagonists

               -  tricyclic antidepressants

               -  daily use of Beta-agonists or steroid inhalers

          -  Participation in another clinical trial /study at the moment or within the last 60
             days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>01 Studienregister MasterAdmins</last_name>
    <role>Study Director</role>
    <affiliation>UniversitaetsSpital Zuerich</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Zurich</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>February 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 17, 2008</study_first_submitted>
  <study_first_submitted_qc>July 18, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 21, 2008</study_first_posted>
  <last_update_submitted>February 16, 2011</last_update_submitted>
  <last_update_submitted_qc>February 16, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 17, 2011</last_update_posted>
  <responsible_party>
    <name_title>PD Dr. Thomas KÃ¼ndig</name_title>
    <organization>University Hospital Zurich</organization>
  </responsible_party>
  <keyword>Rhinoconjunctivitis</keyword>
  <keyword>Allergic</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

